Status:

COMPLETED

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Lead Sponsor:

Jonsson Comprehensive Cancer Center

Conditions:

Ocular Melanoma

Choroidal Melanoma

Eligibility:

All Genders

18+ years

Brief Summary

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a tota...

Eligibility Criteria

Inclusion

  • Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris).
  • Patients 18 years of age or older.
  • Patients able to give informed consent.

Exclusion

  • Patients who refuse to participate in the study.
  • Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
  • Patients who will be moving out of the area of UCLA during the ten years of this study.

Key Trial Info

Start Date :

June 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

174 Patients enrolled

Trial Details

Trial ID

NCT00351728

Start Date

June 1 2006

End Date

August 1 2012

Last Update

July 7 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jules Stein Eye Institute

Los Angeles, California, United States, 90095-7000